The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data
Background: Drug-resistant tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB), constitutes a major obstacle to fulfill end TB strategy globally. Although fluoroquinolones (FQs), linezolid (LZD) and bedaquiline (BDQ) were classified as Group A drugs for MDR-TB treatment, our know...
Saved in:
Main Authors: | Shanshan Li (Author), Yaoju Tan (Author), Yufeng Deng (Author), Guanghong Bai (Author), Mingxiang Huang (Author), Yuanyuan Shang (Author), Yufeng Wang (Author), Zhongtan Xue (Author), Xuxia Zhang (Author), Wei Wang (Author), Junhua Pan (Author), Yu Pang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations
by: Wei Wang, et al.
Published: (2022) -
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid.
by: Juliano Timm, et al.
Published: (2023) -
The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran
by: Nahid Madadi-Goli, et al.
Published: (2024) -
Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
by: Yangming Ding, et al.
Published: (2023) -
Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study
by: Haiping Guo, et al.
Published: (2023)